Literature DB >> 9078679

Dendritic cells hold promise for immunotherapy.

G Girolomoni1, P Ricciardi-Castagnoli.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9078679     DOI: 10.1016/s0167-5699(97)01030-x

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  20 in total

1.  Influence of granulocyte macrophage colony stimulating factor and tumor necrosis factor on anti-hepatoma activities of human dendritic cells.

Authors:  Jin-Kun Zhang; Jin-Lun Sun; Hai-Bin Chen; Yang Zeng; Yao-Jun Qu
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.

Authors:  G A Van den Bosch; P Ponsaerts; G Nijs; M Lenjou; G Vanham; D R Van Bockstaele; Z N Berneman; V F I Van Tendeloo
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

3.  Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.

Authors:  Joanne M Fraser; Claire N Janicki; Ben J E Raveney; David J Morgan
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

Review 4.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.

Authors:  K Kirchhoff; O Weinmann; J Zwirner; G Begemann; O Götze; A Kapp; T Werfel
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

6.  Role of macrophage colony-stimulating factor in the differentiation and expansion of monocytes and dendritic cells from CD34+ progenitor cells.

Authors:  A W Kamps; D Hendriks; J W Smit; E Vellenga
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

7.  Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.

Authors:  S Hong; H Li; J Qian; J Yang; Y Lu; Q Yi
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

8.  Interactions of dendritic cells with fibronectin and endothelial cells.

Authors:  C Jancic; H E Chuluyan; A Morelli; A Larregina; E Kolkowski; M Saracco; M Barboza; W S Leiva; L Fainboim
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

Review 9.  Immunological weapons against acute myeloid leukaemia.

Authors:  Joanna Galea-Lauri
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

10.  Ex vivo enhancement of antigen-presenting function of dendritic cells and its application for DC-based immunotherapy.

Authors:  Mie Nieda; Mai Tomiyama; Kohji Egawa
Journal:  Hum Cell       Date:  2003-12       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.